Patents by Inventor Lewis Lanier

Lewis Lanier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20060280755
    Abstract: The present invention relates to methods and compositions for treating and/or preventing autoimmune and/or inflammatory disease. In particular, the present invention provides therapeutics for impairing the expansion and function of autoreactive T cells, NK cells and/or NKT cells, by modulating NKG2D.
    Type: Application
    Filed: May 5, 2006
    Publication date: December 14, 2006
    Applicant: The Regents of the University of California
    Inventors: Jody Baron, Sang-Mo Kang, Lewis Lanier
  • Publication number: 20060084121
    Abstract: Nucleic acids encoding mammalian, e.g., primate, receptors, purified proteins and fragments thereof. Antibodies, both polyclonal and monoclonal, are also provided. Methods of using the compositions for both diagnostic and therapeutic utilities are described.
    Type: Application
    Filed: September 22, 2005
    Publication date: April 20, 2006
    Inventors: A. Barclay, Marion Brown, Daniel Gorman, Lewis Lanier, Gavin Wright, Holly Cherwinski, Joseph Phillips, Robert Hoek, Jonathan Sedgwick
  • Publication number: 20050287582
    Abstract: Nucleic acids encoding various monocyte cell proteins from a primate, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Application
    Filed: August 4, 2005
    Publication date: December 29, 2005
    Applicant: Schering Corporation
    Inventors: Gosse Adema, Linde Meyaard, Daniel Gorman, Terrill McClanahan, Sandra Zurawski, Gerard Zurawski, Lewis Lanier, Joseph Phillips
  • Publication number: 20050084900
    Abstract: The purification and isolation of various genes which encode mammalian cell surface polypeptides. Nucleic acids, proteins, antibodies, and other reagents useful in modulating development of cells, e.g., lymphoid and myeloid, are provided, along with methods for their use.
    Type: Application
    Filed: July 8, 2002
    Publication date: April 21, 2005
    Inventors: Alexander Bakker, Joseph Phillips, Lewis Lanier
  • Publication number: 20050059808
    Abstract: Nucleic acids encoding various monocyte cell proteins from a primate, reagents related thereto, including specific antibodies, and purified proteins are described. Methods of using said reagents and related diagnostic kits are also provided.
    Type: Application
    Filed: February 11, 2004
    Publication date: March 17, 2005
    Inventors: Gosse Adema, Linde Meyaard, Daniel Gorman, Terrill McClanahan, Sandra Zurawski, Gerard Zurawski, Lewis Lanier, Joseph Phillips
  • Patent number: 4607007
    Abstract: A method for distinguishing multiple subpopulations of a cell sample whereby human natural killer cells subpopulations can be monitored. The method utilizes two monoclonal antibodies identified as anti-Leu-7 and anti-Leu-11.
    Type: Grant
    Filed: April 7, 1983
    Date of Patent: August 19, 1986
    Assignee: Becton, Dickinson and Company
    Inventors: Lewis Lanier, Noel L. Warner
  • Patent number: 4599304
    Abstract: A method of distinguishing multiple subpopulations of a cell sample whereby resting and activated human natural killer cells subpopulations can be monitored. This method utilizes two monoclonal antibodies identified as anti-Leu 11 and anti-DR (or anti-Leu 10 or anti-transferrin receptor).
    Type: Grant
    Filed: October 7, 1983
    Date of Patent: July 8, 1986
    Assignee: Becton, Dickinson and Company
    Inventors: Lewis Lanier, Joseph Phillips